BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2440444)

  • 1. Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase.
    Dietz BM; Kang YH; Liu G; Eggler AL; Yao P; Chadwick LR; Pauli GF; Farnsworth NR; Mesecar AD; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2005 Aug; 18(8):1296-305. PubMed ID: 16097803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct oligomerization and NADPH binding modes observed between L. donovani and human quinone oxidoreductases.
    Vishwakarma C; Ansari A; Pratap JV
    Biochem Biophys Res Commun; 2024 Jan; 690():149096. PubMed ID: 37988924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury.
    Aleksunes LM; Goedken M; Manautou JE
    World J Gastroenterol; 2006 Mar; 12(12):1937-40. PubMed ID: 16610002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
    Schlager JJ; Powis G
    Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.
    Powis G; Seewald MJ; Melder D; Hoke M; Gratas C; Christensen TA; Chapman DE
    Cancer Chemother Pharmacol; 1992; 31(3):223-8. PubMed ID: 1464160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth factor binding and intracellular Ca2+ signalling by dextran sulfates of different sizes and degrees of sulfation.
    Powis G; Seewald M; Hoke M
    Cancer Chemother Pharmacol; 1992; 30(6):483-6. PubMed ID: 1394806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.
    Horie S
    Kitasato Arch Exp Med; 1990 Apr; 63(1):11-30. PubMed ID: 2125671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinones and glutathione metabolism.
    Watanabe N; Dickinson DA; Liu RM; Forman HJ
    Methods Enzymol; 2004; 378():319-40. PubMed ID: 15038978
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.
    Powis G; See KL; Santone KS; Melder DC; Hodnett EM
    Biochem Pharmacol; 1987 Aug; 36(15):2473-9. PubMed ID: 2440444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
    Powis G; Hodnett EM; Santone KS; See KL; Melder DC
    Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenobarbital-induced cytoprotective mechanisms in menadione metabolism: the role of glutathione reductase and DT-diaphorase.
    Utley WS; Mehendale HM
    Int J Biochem; 1990; 22(9):957-67. PubMed ID: 1704318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
    Walton MI; Smith PJ; Workman P
    Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dicumarol, a Nad(P)h: quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes.
    Kishi T; Takahashi T; Mizobuchi S; Mori K; Okamoto T
    Free Radic Res; 2002 Apr; 36(4):413-9. PubMed ID: 12069105
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.